Invites Ventures, established in 2019, is a Venture Capital with New Technology Venture Capital Business license (“Shinkisa” license).
Invites Ventures is wholly owned by CG Invites (KOSDAQ listed) and its focal area of investment was Biotech (primarily new drug pipeline) however, as of current, its portfolio has spanned beyond that of Biotech and has exposures in non-bio areas such as Deep Tech (application used for defense sector) and Personal Mobility to name a few.
Furthermore, overall portfolio is not necessarily bound within Korea but has presence in U.S and Japan. Invites Ventures is continuously seeking for investment opportunities with high growth prospect sectors (Artificial Intelligence, Innovative Medical Devices, Digital Healthcare and etc).
Invites Ventures strives not only to be best but aspires to be better. We are agile and open to innovative ideas that are in need capital. We crave to bring positive impact to the world and wish to be successful together with the founders.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Seoul, 10, Gukjegeumyung-Ro, Yeongdeungpo-Gu, Kr
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://invitesventures.com
- Keywords
- 서울특별시.
- HQ
- Seoul, 10, Gukjegeumyung-ro, Yeongdeungpo-gu
Invites Ventures Questions
Invites Ventures's website is http://invitesventures.com
Invites Ventures's LinkedIn profile is https://kr.linkedin.com/company/invites-ventures
Invites Ventures has
3 employees.
View email and phone details for 3
employees at Invites Ventures.
Invites Ventures's industry is
Venture Capital and Private Equity Principals
Invites Ventures's top competitors are
경영전략학회 S&d,
Translink Investment,
Gs Ventures,
Republic Of Korea Army,
Hanbit Investment,
Gs Ventures,
Ascent Equity Partners,
Es Investor,
Imm Private Equity,
Leestone Co., Ltd..
Invites Ventures's categories are Venture Capital and Private Equity Principals
Invites Ventures's founding year is 2019
